Does Heart Rate Variance (HRV) Biofeedback Help Regulate Emotions and Improve Mindfulness in Mentally Unwell Offenders?

Overview

14 participants residing in a forensic psychiatric hospital completed 15 Heart Rate Variance (HRV) biofeedback sessions. They completed 4 psychometric questionnaires, pre, during and post biofeedback training.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 27, 2018

Detailed Description

This study aimed to establish whether Heart Rate Variance (HRV) biofeedback improved HRV coherence as well as psychological well-being (depression, anxiety, emotion regulation, and mindfulness) over the course of 15 biofeedback sessions in a sample of 14 patients with varying diagnoses; Paranoid Schizophrenia, Schizoaffective Disorder, Personality Disorder or Mixed Diagnosis. All 14 participants (n=10 male, n=4 female) participated in 15 biofeedback sessions. The study was researched and treatment was facilitated by a trainee forensic psychologist working with both male and female offenders residing within a Forensic Psychiatric Hospital, on both low and medium secure wards. An average coherence percentage was captured using the Wild Devine Programme® Relaxing Rhythms software for each session. Quantitative data were collected and analysed before, during and after biofeedback treatment to assess whether there was improvement in psychometric measures of depression, anxiety, emotion regulation and facets of mindfulness. A quasi experimental 'A-B-A design' was employed to assess the research questions.

Interventions

  • Other: Difficulties in Emotional Regulation Scale, Five Facet Mindfulness Questionnaire, Becks Depression and Becks Anxiety
    • Patients asked to complete these 4 questionnaires pre, during and post biofeedback training
  • Behavioral: HRV Biofeedback (Healing Rhythms)
    • Sensors placed on fingers to capture heart rate and skin temperature

Arms, Groups and Cohorts

  • Experimental: Heart Rate Variance (HRV) biofeedback training
    • Patients to participate in 15 biofeedback sessions, 3 times a week (5 weeks in total).

Clinical Trial Outcome Measures

Primary Measures

  • Difficulties in Emotional Regulation (DERS)
    • Time Frame: 30 minutes (pre, during and post biofeedback training)
    • a 36 item self-report questionnaire developed to assess adult difficulties in emotional regulation. six specific dimensions which include; difficulties accepting emotional responses (acceptance), controlling impulse behaviours (impulse), emotional awareness (awareness), emotional clarity (clarity), assessing emotion regulation strategies (strategies) and engaging in goal oriented behaviour when emotionally aroused (goals). Internal consistency for Cronbach’s alpha was .93 for the total scale and for DERS-A, .85, DERS-I, .89, DERS-A, .86, DERS-C, .80, DERS-S, .88, and DERS-G, .84
  • Five Facet Mindfulness Questionnaire (FFMQ)
    • Time Frame: 30 minutes (pre, during and post biofeedback training)
    • Consists of 39 items assessing five facets of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Items are rated on a Likert scale ranging from 1 (never or very rarely true) to 5 (very often or always true). The FFMQ has been shown to have good internal consistency and significant relationships in the predicted directions with a variety of constructs related to mindfulness. The internal consistencies (Cronbach α) for these facets have been reported as 0.75 for FFMQ-NR, 0.83 for FFMQ-O, 0.87 for FFMQ-A, 0.91 for FFMQ-D, and 0.87 for FFMQ-NJ
  • Becks Depression Inventory (BDI-II)
    • Time Frame: 15 minutes (pre, during and post biofeedback training)
    • A 21-item self-report scale that surveys common symptoms of depression on a 4-point scale ranging from 0 to 3. Internal consistency of the BDI-II was demonstrated to be good (Cronbach’s α=.91; Beck, Steer, Ball et al., 1996) and the 1-week test-retest reliability was shown to be high.
  • Becks Anxiety Inventory (BAI)
    • Time Frame: 15 minutes (pre, during and post biofeedback training)
    • Consists of 21 statements used to measure the severity of an individual’s anxiety. When completing the BAI, individuals rate the severity of each symptom on a 4-point scale ranging from 0 (not at all) to 3 (severely-I could barely stand it). Good internal consistency (Cronbach’s α=.92) and test-retest reliability (r=.75).

Secondary Measures

  • Heart Rate Variance (HRV) biofeedback
    • Time Frame: 10 minutes per session
    • Heart rate coherence scores were assessed using the IoM butterfly Grapher. The coherence score is based upon a composite score of 0-100%; 0 being no coherence, 100% being perfect coherence.

Participating in This Clinical Trial

Inclusion Criteria

  • Male and female offenders aged 18 and above. – Male and female offenders who reside in a medium and low Forensic Psychiatric Hospital. – Individuals who have the capacity to consent to take part in the research – Individuals deemed mentally stable and were found to have capacity to consent by their Multi-Disciplinary Team (MDT). Exclusion Criteria:

  • Individuals under the age of 18. – Individuals who are not detained in a Forensic Psychiatric Hospital. – Individuals deemed not well enough to consent by their Multi-Disciplinary Team (MDT). – A level of cognitive impairment determined by diagnosis that would prevent individuals from understanding the feedback obtained. via pictorial or verbal prompts – Individuals with specific breathing difficulties (e.g., chronic obstructive pulmonary disease) that would restrict them from being able to practice the breathing techniques.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 77 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Birmingham
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Georgina V Atkinson, Principal Investigator, University of Birmingham

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.